Morgan Stanley Edwards Lifesciences Corp Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Morgan Stanley holds 7,494,592 shares of EW stock, worth $577 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,494,592

Previous 7,349,244 1.98%

Holding current value

$577 Million

Previous $533 Million 10.04%

% of portfolio

0.04%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$67.07 - $78.22 $9.75 Million - $11.4 Million	145,348 Added 1.98%	7,494,592 $586 Million
Q1 2025 May 15, 2025	BUY	$67.95 - $76.19 $14.4 Million - $16.2 Million	212,593 Added 2.98%	7,349,244 $533 Million
Q4 2024 Feb 14, 2025	BUY	$64.54 - $75.92 $91.4 Million - $107 Million	1,415,889 Added 24.75%	7,136,651 $528 Million
Q3 2024 May 14, 2025	SELL	$59.7 - $93.78 $49.5 Million - $77.8 Million	-829,710 Reduced 12.67%	5,720,762 $378 Million
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $49.5 Million - $77.8 Million	-829,710 Reduced 12.67%	5,720,762 $378 Million
Q2 2024 May 14, 2025	SELL	$84.3 - $94.31 $49.4 Million - $55.3 Million	-586,179 Reduced 8.21%	6,550,472 $605 Million
Q2 2024 Oct 17, 2024	BUY	$84.3 - $94.31 $31.3 Million - $35 Million	371,410 Added 6.01%	6,550,472 $605 Million
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $31.3 Million - $35 Million	371,410 Added 6.01%	6,550,472 $605 Million
Q1 2024 Oct 17, 2024	SELL	$72.54 - $95.56 $26.9 Million - $35.5 Million	-371,410 Reduced 5.67%	6,179,062 $590 Million
Q1 2024 Aug 16, 2024	BUY	$72.54 - $95.56 $5.14 Million - $6.78 Million	70,901 Added 1.16%	6,179,062 $590 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $5.14 Million - $6.78 Million	70,901 Added 1.16%	6,179,062 $590 Million
Q4 2023 Aug 16, 2024	SELL	$61.71 - $77.76 $27.3 Million - $34.4 Million	-442,311 Reduced 6.75%	6,108,161 $466 Million
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $60.8 Million - $76.6 Million	-985,267 Reduced 13.89%	6,108,161 $466 Million
Q3 2023 Nov 15, 2023	SELL	$69.28 - $93.38 $41 Million - $55.3 Million	-592,418 Reduced 7.71%	7,093,428 $491 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $68.7 Million - $79.7 Million	844,484 Added 12.34%	7,685,846 $725 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $25.4 Million - $28.9 Million	-342,452 Reduced 4.77%	6,841,362 $566 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $58.4 Million - $74.8 Million	855,755 Added 13.52%	7,183,814 $536 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $5.49 Million - $7.16 Million	66,704 Added 1.07%	6,328,059 $523 Million
Q2 2022 Oct 27, 2022	BUY	$86.5 - $128.27 $262 Million - $388 Million	3,023,685 Added 93.39%	6,261,355 $595 Million
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $262 Million - $388 Million	3,023,685 Added 93.39%	6,261,355 $595 Million
Q1 2022 Oct 27, 2022	SELL	$101.96 - $128.34 $308 Million - $388 Million	-3,023,685 Reduced 48.29%	3,237,670 $381 Million
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $46.7 Million - $58.8 Million	-457,979 Reduced 12.39%	3,237,670 $381 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $32.3 Million - $39.7 Million	303,564 Added 8.95%	3,695,649 $479 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $349 Million - $416 Million	3,392,085 New	3,392,085 $384 Million

Others Institutions Holding EW

# of Institutions

1,438

Shares Held

484M

Call Options Held

2.93M

Put Options Held

1.57M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $47.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account